Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Lucid Diagnostics Inc shares valued at $242,292 were purchased by Matheis Dennis on May 20 ’25. At $1.29 per share, Matheis Dennis acquired 187,098 shares. The insider’s holdings grew to 187,098 shares worth approximately $0.19 million following the completion of this transaction.
Also, Matheis Dennis purchased 129,684 shares, netting a total of over 171,520 in proceeds. Following the buying of shares at $1.32 each, the insider now holds 316,782 shares.
Before that, Matheis Dennis had added 33,218 shares to its account. In a trade valued at $43,795, the Director bought Lucid Diagnostics Inc shares for $1.32 each. Upon closing the transaction, the insider’s holdings increased to 33,218 shares, worth approximately $0.35 million.
As published in their initiating research note from Ascendiant Capital Markets on December 27, 2021, Lucid Diagnostics Inc [LUCD] has been a Buy and the price target has been revised to $16. Analysts at Needham started covering the stock with ‘”a Buy”‘ outlook in a report released in early November. As of November 08, 2021, Cantor Fitzgerald has initiated its “an Overweight” rating for LUCD. Earlier on November 08, 2021, BTIG Research initiated its rating. Their recommendation was “a Buy” for LUCD stock.
Analyzing LUCD Stock Performance
On last trading session,, Lucid Diagnostics Inc [NASDAQ: LUCD] plunged -6.48% to $1.01. The stock’s lowest price that day was $1.0, but it reached a high of $1.11 in the same session. During the last five days, there has been a drop of approximately -9.82%. Over the course of the year, Lucid Diagnostics Inc shares have jumped approximately 17.44%.
Support And Resistance Levels for Lucid Diagnostics Inc (LUCD)
RSI (Relative Strength Index) is 34.14 on the 14-day chart, showing neutral technical sentiment.
Is Lucid Diagnostics Inc subject to short interest?
Stocks of Lucid Diagnostics Inc saw a sharp rise in short interest on 2025-07-15 jumping by 3.13 million shares to 4.79 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 1.66 million shares. A jump of 65.43% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.08 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.08.
Which companies own the most shares of Lucid Diagnostics Inc (LUCD)?
In terms of Lucid Diagnostics Inc share price expectations, FactSet research, analysts set an average price target of 2 in the next 12 months, up nearly 85.19% from the previous closing price of $1.08. Analysts anticipate Lucid Diagnostics Inc stock to reach 2 by 2025, with the lowest price target being 2. In spite of this, 3 analysts ranked Lucid Diagnostics Inc stock as Buy at the end of 2025.
